Privia Health Group Management
Management criteria checks 2/4
Privia Health Group's CEO is Parth Mehrotra, appointed in Jul 2023, has a tenure of less than a year. total yearly compensation is $17.07M, comprised of 3.2% salary and 96.8% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth $5.25M. The average tenure of the management team and the board of directors is 3.5 years and 2.4 years respectively.
Key information
Parth Mehrotra
Chief executive officer
US$17.1m
Total compensation
| CEO salary percentage | 3.2% |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 3.5yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers
Mar 03
The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)
Feb 27There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Jan 31Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching
Dec 03Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues
Nov 06Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business
Aug 08Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate
Mar 17Privia Health: In Line For Solid FY22, Hold On Valuation
Sep 15Privia Health Group reports Q2 earnings beat; raises FY22 outlook
Aug 11Privia Health Group Grows But Operating Results Await
Jun 20Is Privia Health Group, Inc. (NASDAQ:PRVA) Trading At A 48% Discount?
Feb 09Privia Health Group: Not Healthy Yet
Feb 06A Look At The Fair Value Of Privia Health Group, Inc. (NASDAQ:PRVA)
Nov 11Calculating The Intrinsic Value Of Privia Health Group, Inc. (NASDAQ:PRVA)
Jul 29Privia Health Group, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 28Disrupting Healthcare - IPO Interview With Privia Health CEO Shawn Morris (Video)
May 03Privia Health Group: Good Intentions Do Not Automatically Make A Good Investment
May 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$17m | US$542k | US$23m |
| Sep 30 2023 | n/a | n/a | US$38m |
| Jun 30 2023 | n/a | n/a | US$34m |
| Mar 31 2023 | n/a | n/a | US$16m |
| Dec 31 2022 | US$1m | US$475k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$38m |
| Jun 30 2022 | n/a | n/a | -US$49m |
| Mar 31 2022 | n/a | n/a | -US$211m |
| Dec 31 2021 | US$52m | US$475k | -US$188m |
| Sep 30 2021 | n/a | n/a | -US$172m |
| Jun 30 2021 | n/a | n/a | -US$147m |
| Mar 31 2021 | n/a | n/a | US$31m |
| Dec 31 2020 | US$1m | US$412k | US$31m |
Compensation vs Market: Parth's total compensation ($USD17.07M) is above average for companies of similar size in the US market ($USD5.61M).
Compensation vs Earnings: Parth's compensation has been consistent with company performance over the past year.
CEO
Parth Mehrotra (44 yo)
less than a year
Tenure
US$17,073,185
Compensation
Mr. Parth Mehrotra serves as Chief Executive Officer and Director of Privia Health Group, Inc. since July 1, 2023. He had been the President and Chief Operating Officer of Privia Health Group, Inc. since 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$17.07m | 0.25% $ 5.2m | |
| Executive VP | 2.1yrs | US$2.32m | 0.23% $ 4.9m | |
| Executive Officer | less than a year | US$1.87m | 0.0046% $ 99.0k | |
| Chief Operating Officer | less than a year | no data | no data | |
| Executive VP & Chief Technology Officer | 8yrs | no data | no data | |
| Senior Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior VP of Internal Audit & Chief Compliance Officer | 4.8yrs | no data | no data | |
| Executive VP | less than a year | no data | no data | |
| Chief People Officer | 7.7yrs | no data | no data | |
| Senior VP & Chief Growth Officer | no data | no data | no data | |
| Executive Vice President of Medical Groups | 8.2yrs | no data | no data | |
| Chief Clinical Officer | 6.4yrs | no data | no data |
3.5yrs
Average Tenure
53yo
Average Age
Experienced Management: PRVA's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$17.07m | 0.25% $ 5.2m | |
| Independent Director | 2yrs | US$275.06k | 0.0060% $ 127.2k | |
| Independent Director | less than a year | US$202.69k | 0% $ 0 | |
| Independent Director | less than a year | no data | 4.48% $ 95.7m | |
| Independent Director | 3yrs | US$290.06k | 0.013% $ 270.5k | |
| Independent Chairman | 3.3yrs | US$335.06k | 0.013% $ 270.5k | |
| Director | less than a year | US$211.02k | 0% $ 0 | |
| Director | 5.9yrs | US$679.52k | 0.089% $ 1.9m | |
| Independent Director | no data | US$275.06k | 0.013% $ 270.5k | |
| Independent Director | 3yrs | US$300.06k | 0.020% $ 426.9k | |
| Independent Director | 2.8yrs | US$275.06k | 0.0096% $ 204.5k |
2.4yrs
Average Tenure
60yo
Average Age
Experienced Board: PRVA's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.